Illuminare-1
Showing 51 - 75 of >10,000
Type 1 Diabetes Trial in Pamplona (Diactive-1 application)
Recruiting
- Type 1 Diabetes
- Diactive-1 application
-
Pamplona, Navarra, Spain
- +1 more
Sep 20, 2023
Breast Cancer, Oral Cancer Trial in Mumbai (Cannabis capsules)
Active, not recruiting
- Breast Cancer
- Oral Cancer
- Cannabis capsules
-
Mumbai, Maharashtra, India
- +1 more
Jul 22, 2023
Cancer Trial (Antibody-Drug Conjugate)
Not yet recruiting
- Cancer
- Antibody-Drug Conjugate
- (no location specified)
Aug 23, 2023
Advanced Solid Tumor Trial in São Paulo, Santo André (IMX-110 combined with Tislelizumab)
Recruiting
- Advanced Solid Tumor
- IMX-110 combined with Tislelizumab
-
São Paulo, Sao Paulo, Brazil
- +1 more
Apr 28, 2023
Healthy Trial in Berlin, Hamburg (LY06006 (Denosumab Biosimilar), US-Prolia (Denosumab), EU-Prolia)
Completed
- Healthy
- LY06006 (Denosumab Biosimilar)
- +2 more
-
Berlin, Germany
- +1 more
Oct 18, 2023
Hepatorenal Syndrome at Methodist Dallas Medical Center
Recruiting
- Hepatorenal Syndrome
- Hepatorenal Syndrome outcome in Patients at Methodist Health systems
-
Dallas, TexasLiver Institute of Methodist Dallas Medical Center
Oct 18, 2023
Olfactory Cleft Stenosis and Obstruction on Paranasal Sinus CT
Recruiting
- Olfactory Impairment
-
Nancy, France
- +1 more
Oct 8, 2023
Ulcerative Colitis Trial in Manchester (SOR102, Placebo)
Recruiting
- Ulcerative Colitis
- SOR102
- Placebo
-
Manchester, United KingdomMAC Clinical Research
Oct 6, 2023
Prostate Cancer Trial ([177Lu]Lu-PSMA I&T, Stereotactic Radiotherapy)
Not yet recruiting
- Prostate Cancer
- [177Lu]Lu-PSMA I&T
- Stereotactic Radiotherapy
- (no location specified)
May 30, 2023
Cardiovascular Biomarkers in Peripheral Artery Disease.
Active, not recruiting
- Peripheral Artery Disease
-
Rome, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Feb 24, 2023
Non Small Cell Lung Cancer Trial in Salt Lake City (radiation, device, drug)
Not yet recruiting
- Non Small Cell Lung Cancer
- carboplatin chemotherapy
- +2 more
-
Salt Lake City, UtahHuntsman Cancer Institute
Nov 3, 2023
Developmental Endothelial Locus-1, Platelet Count, and Soluble
Not yet recruiting
- Overweight and Obesity
- Platelet count
- +2 more
-
Aswan, EgyptAswan University Hospital
May 17, 2023
Alcohol Use Disorder Trial (Prazosin + cyproheptadine, KT110)
Not yet recruiting
- Alcohol Use Disorder
- Prazosin + cyproheptadine
- KT110
- (no location specified)
Nov 27, 2023
Joint Pain Trial in Mumbai, Nashik, Panvel (E-PR-01 (Low dose), E-PR-01 (High Dose), Placebo)
Not yet recruiting
- Joint Pain
- E-PR-01 (Low dose)
- +2 more
-
Mumbai, Maharashtra, India
- +3 more
Apr 24, 2023
Resuscitative Thoracotomy Practices
Enrolling by invitation
- Resuscitative Thoracotomy Practices
- Resuscitative thoracotomies
-
Dallas, TexasMethodist Dallas Medical Center
Jul 6, 2023
Advanced Solid Tumors Trial in Canada, United States (LCB84, Anti-PD-1 mAb)
Not yet recruiting
- Advanced Solid Tumors
- LCB84
- Anti-PD-1 monoclonal antibody
-
Los Angeles, California
- +6 more
Jul 4, 2023
Infectious Diseases Trial in Taichung (cefoperazone sodium and sulbactam sodium)
Active, not recruiting
- Infectious Diseases
- cefoperazone sodium and sulbactam sodium
-
Taichung, TaiwanTaichung Veterans General Hospital
Jan 29, 2023
Non Small Cell Lung Cancer Trial in China (TQB2450 injection + Chemotherapy, TQB2450 injection + Anlotinib Hydrochloride
Recruiting
- Non Small Cell Lung Cancer
- TQB2450 injection + Chemotherapy
- TQB2450 injection + Anlotinib Hydrochloride Capsule
-
Beijing, Beijing, China
- +9 more
Jun 27, 2023
Multiple Myeloma Trial in Roma, Rome (ATAC-seq and ChIP-seq)
Recruiting
- Multiple Myeloma
- ATAC-seq and ChIP-seq
-
Roma, Italy
- +1 more
May 4, 2023
Type 1 Diabetes Trial in Kuwait City (Morning exercise, Afternoon exercise, Habitual physical activity levels)
Not yet recruiting
- Type 1 Diabetes
- Morning exercise
- +2 more
-
Kuwait City, KuwaitDasman Diabetes Institute
May 22, 2023
Osteoarthritis, Knee, Osteoarthritis, Knee Osteoarthritis Trial in Russian Federation (undenaturated collagen type II,
Completed
- Osteoarthritis, Knee
- +6 more
- undenaturated collagen type II, methylsulfonylmethane, boswellia serrata, vitamin D3 (cholecalciferol), vitamin C (ARTNEO)
- Placebo
-
Kazan, Russian Federation
- +11 more
Aug 3, 2023
Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)
Not yet recruiting
- Triple Negative Breast Cancer
- Aldesleukin
- +12 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 9, 2023
Anxiety, Type 1 Diabetes, Quality of Life Trial in Tampa (Mindfulness training)
Recruiting
- Anxiety
- +2 more
- Mindfulness training
-
Tampa, FloridaUniversity of South Florida College of Nursing
Nov 14, 2023